Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 6 | 2019 | 111 | 1.680 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2019 | 89 | 1.460 |
Why?
|
| Arthroplasty, Replacement, Hip | 3 | 2022 | 50 | 1.410 |
Why?
|
| Pulmonary Embolism | 3 | 2019 | 49 | 1.310 |
Why?
|
| Knee Joint | 2 | 2018 | 142 | 1.170 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2018 | 39 | 1.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 91 | 1.070 |
Why?
|
| Medicare | 5 | 2022 | 206 | 0.980 |
Why?
|
| Postoperative Complications | 7 | 2022 | 780 | 0.950 |
Why?
|
| Neoplasms | 4 | 2022 | 726 | 0.930 |
Why?
|
| Orthopedics | 2 | 2023 | 90 | 0.930 |
Why?
|
| Humans | 40 | 2023 | 32005 | 0.890 |
Why?
|
| Case-Control Studies | 7 | 2022 | 898 | 0.760 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 765 | 0.760 |
Why?
|
| Osteosarcoma | 2 | 2019 | 11 | 0.720 |
Why?
|
| Retrospective Studies | 12 | 2022 | 3509 | 0.720 |
Why?
|
| United States | 11 | 2023 | 3939 | 0.710 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 519 | 0.690 |
Why?
|
| Hemophilia B | 1 | 2019 | 6 | 0.690 |
Why?
|
| Aged | 16 | 2022 | 10301 | 0.680 |
Why?
|
| Shoulder Joint | 1 | 2022 | 126 | 0.680 |
Why?
|
| Osteoporosis | 1 | 2020 | 70 | 0.680 |
Why?
|
| Hemophilia A | 1 | 2019 | 25 | 0.660 |
Why?
|
| Sarcoma | 3 | 2018 | 73 | 0.660 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 57 | 0.630 |
Why?
|
| Teaching | 1 | 2019 | 62 | 0.630 |
Why?
|
| Middle Aged | 17 | 2022 | 11817 | 0.610 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 23 | 0.610 |
Why?
|
| Reimbursement Mechanisms | 1 | 2017 | 13 | 0.600 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 127 | 0.600 |
Why?
|
| Hip Fractures | 1 | 2017 | 31 | 0.590 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 37 | 0.590 |
Why?
|
| Nutritional Status | 1 | 2017 | 75 | 0.580 |
Why?
|
| Antioxidants | 1 | 2018 | 115 | 0.570 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 3990 | 0.570 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 183 | 0.570 |
Why?
|
| Patient Readmission | 1 | 2017 | 126 | 0.550 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 4 | 0.530 |
Why?
|
| Spasm | 1 | 2016 | 6 | 0.530 |
Why?
|
| Fractures, Bone | 1 | 2017 | 148 | 0.530 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 32 | 0.490 |
Why?
|
| Male | 17 | 2021 | 19165 | 0.490 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 367 | 0.480 |
Why?
|
| Continuity of Patient Care | 1 | 2015 | 69 | 0.470 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 471 | 0.470 |
Why?
|
| Angiotensin I | 1 | 2016 | 241 | 0.460 |
Why?
|
| Peptide Fragments | 1 | 2016 | 399 | 0.430 |
Why?
|
| Vascular Malformations | 1 | 2012 | 9 | 0.420 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 8 | 0.410 |
Why?
|
| Diphosphonates | 1 | 2012 | 9 | 0.410 |
Why?
|
| Alendronate | 1 | 2012 | 11 | 0.410 |
Why?
|
| Catheter Ablation | 1 | 2012 | 67 | 0.400 |
Why?
|
| Brachytherapy | 1 | 2012 | 24 | 0.400 |
Why?
|
| Fractures, Stress | 1 | 2012 | 11 | 0.400 |
Why?
|
| Risk Assessment | 1 | 2017 | 1426 | 0.390 |
Why?
|
| Femoral Fractures | 1 | 2012 | 40 | 0.390 |
Why?
|
| Carbapenems | 1 | 2021 | 7 | 0.390 |
Why?
|
| Cephalosporins | 1 | 2021 | 9 | 0.390 |
Why?
|
| Mouth Mucosa | 1 | 2021 | 30 | 0.380 |
Why?
|
| Female | 15 | 2021 | 19959 | 0.370 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 43 | 0.350 |
Why?
|
| Wound Healing | 1 | 2021 | 185 | 0.350 |
Why?
|
| Fasting | 1 | 2020 | 95 | 0.350 |
Why?
|
| Dyslipidemias | 1 | 2020 | 53 | 0.340 |
Why?
|
| Regenerative Medicine | 1 | 2021 | 201 | 0.310 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 23 | 0.310 |
Why?
|
| Secondary Prevention | 2 | 2020 | 63 | 0.300 |
Why?
|
| Treatment Outcome | 4 | 2022 | 3306 | 0.290 |
Why?
|
| Cardiology Service, Hospital | 1 | 2017 | 23 | 0.280 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 31 | 0.280 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 411 | 0.280 |
Why?
|
| Animals | 6 | 2022 | 7541 | 0.260 |
Why?
|
| Adult | 8 | 2022 | 9345 | 0.260 |
Why?
|
| Dystonia | 1 | 2015 | 12 | 0.250 |
Why?
|
| Reoperation | 2 | 2022 | 226 | 0.230 |
Why?
|
| Risk Factors | 3 | 2020 | 3876 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Length of Stay | 2 | 2017 | 314 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Bone Density Conservation Agents | 2 | 2020 | 23 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Comorbidity | 3 | 2022 | 566 | 0.210 |
Why?
|
| Hypertension | 1 | 2020 | 959 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 290 | 0.210 |
Why?
|
| Tissue Scaffolds | 2 | 2021 | 415 | 0.210 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Employment | 1 | 2023 | 49 | 0.210 |
Why?
|
| Obesity | 1 | 2020 | 1175 | 0.200 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1128 | 0.200 |
Why?
|
| Prosthesis Failure | 1 | 2022 | 45 | 0.200 |
Why?
|
| Medicaid | 1 | 2022 | 94 | 0.200 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 9 | 0.190 |
Why?
|
| Papillomaviridae | 1 | 2020 | 22 | 0.180 |
Why?
|
| Mice | 3 | 2022 | 2484 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2017 | 129 | 0.180 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 58 | 0.180 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 74 | 0.180 |
Why?
|
| Decompression, Surgical | 1 | 2021 | 55 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 918 | 0.180 |
Why?
|
| Lumbar Vertebrae | 1 | 2021 | 101 | 0.180 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1022 | 0.170 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 15 | 0.170 |
Why?
|
| Prosthesis-Related Infections | 1 | 2019 | 22 | 0.170 |
Why?
|
| Osteoblastoma | 1 | 2019 | 1 | 0.170 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 122 | 0.170 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2019 | 2 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Postoperative Hemorrhage | 1 | 2019 | 42 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 49 | 0.170 |
Why?
|
| Blood Transfusion | 1 | 2019 | 73 | 0.170 |
Why?
|
| Wounds and Injuries | 1 | 2022 | 253 | 0.160 |
Why?
|
| Comprehension | 1 | 2019 | 19 | 0.160 |
Why?
|
| Giant Cell Tumor of Bone | 1 | 2018 | 5 | 0.160 |
Why?
|
| Synovitis, Pigmented Villonodular | 1 | 2018 | 6 | 0.160 |
Why?
|
| Sarcoma, Synovial | 1 | 2018 | 6 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2020 | 130 | 0.160 |
Why?
|
| Neurilemmoma | 1 | 2018 | 16 | 0.160 |
Why?
|
| Gout | 1 | 2018 | 14 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 20 | 0.160 |
Why?
|
| Emotions | 1 | 2019 | 58 | 0.160 |
Why?
|
| Lymphoma | 1 | 2018 | 35 | 0.160 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2018 | 15 | 0.160 |
Why?
|
| Osteoarthritis, Knee | 1 | 2019 | 90 | 0.150 |
Why?
|
| Matched-Pair Analysis | 1 | 2017 | 12 | 0.150 |
Why?
|
| Breast Neoplasms, Male | 1 | 2017 | 11 | 0.150 |
Why?
|
| Chondrosarcoma | 1 | 2017 | 7 | 0.150 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2018 | 19 | 0.150 |
Why?
|
| Cryptococcosis | 1 | 2017 | 5 | 0.150 |
Why?
|
| Opportunistic Infections | 1 | 2017 | 17 | 0.150 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 182 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2017 | 97 | 0.150 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 45 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 99 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2017 | 22 | 0.150 |
Why?
|
| ROC Curve | 1 | 2017 | 164 | 0.150 |
Why?
|
| Hand | 1 | 2017 | 66 | 0.140 |
Why?
|
| Osteoarthritis | 1 | 2017 | 79 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 472 | 0.140 |
Why?
|
| Dietary Supplements | 1 | 2018 | 185 | 0.140 |
Why?
|
| Acrospiroma | 1 | 2016 | 4 | 0.130 |
Why?
|
| Sweat Gland Neoplasms | 1 | 2016 | 7 | 0.130 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.130 |
Why?
|
| Bone Density | 1 | 2018 | 205 | 0.130 |
Why?
|
| Arthroscopy | 1 | 2018 | 239 | 0.130 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 48 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 684 | 0.130 |
Why?
|
| Hindlimb | 1 | 2016 | 54 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 93 | 0.130 |
Why?
|
| Fibrosis | 1 | 2016 | 120 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 246 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 226 | 0.130 |
Why?
|
| Logistic Models | 1 | 2017 | 781 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2022 | 469 | 0.130 |
Why?
|
| Carcinoma | 1 | 2016 | 91 | 0.120 |
Why?
|
| Bone Nails | 1 | 2015 | 32 | 0.120 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2015 | 34 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 463 | 0.120 |
Why?
|
| Bone Plates | 1 | 2015 | 66 | 0.120 |
Why?
|
| Radius Fractures | 1 | 2015 | 60 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 582 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 538 | 0.120 |
Why?
|
| Disease Progression | 1 | 2016 | 594 | 0.120 |
Why?
|
| Joint Instability | 1 | 2015 | 76 | 0.110 |
Why?
|
| Referral and Consultation | 1 | 2015 | 141 | 0.110 |
Why?
|
| Phlebography | 1 | 2012 | 26 | 0.110 |
Why?
|
| Veins | 1 | 2012 | 29 | 0.110 |
Why?
|
| Young Adult | 3 | 2019 | 2636 | 0.100 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 88 | 0.100 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2022 | 9 | 0.100 |
Why?
|
| Wound Infection | 1 | 2012 | 10 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2022 | 107 | 0.100 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2012 | 34 | 0.100 |
Why?
|
| Imidazoles | 1 | 2012 | 91 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 104 | 0.100 |
Why?
|
| Adolescent | 3 | 2019 | 3539 | 0.100 |
Why?
|
| Epithelium | 1 | 2021 | 30 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 1 | 2021 | 8 | 0.100 |
Why?
|
| Radiography | 1 | 2012 | 376 | 0.090 |
Why?
|
| Ketone Bodies | 1 | 2020 | 8 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 560 | 0.090 |
Why?
|
| Mutation | 1 | 2022 | 489 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 125 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2021 | 355 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 231 | 0.080 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2018 | 19 | 0.080 |
Why?
|
| Virus Diseases | 1 | 2018 | 22 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2018 | 81 | 0.070 |
Why?
|
| Hospitalization | 2 | 2022 | 470 | 0.070 |
Why?
|
| Thoracic Surgery | 1 | 2017 | 6 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2022 | 1817 | 0.070 |
Why?
|
| Child | 2 | 2019 | 2438 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2017 | 53 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1328 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2018 | 406 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 73 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2017 | 185 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2018 | 604 | 0.060 |
Why?
|
| Age Factors | 1 | 2017 | 1188 | 0.050 |
Why?
|
| Trauma Centers | 1 | 2022 | 82 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1514 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2021 | 11 | 0.050 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 1 | 0.050 |
Why?
|
| Germinal Center | 1 | 2020 | 5 | 0.050 |
Why?
|
| Diskectomy | 1 | 2021 | 14 | 0.050 |
Why?
|
| Laminectomy | 1 | 2021 | 16 | 0.050 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 13 | 0.050 |
Why?
|
| Plasma Cells | 1 | 2020 | 11 | 0.050 |
Why?
|
| Spinal Fusion | 1 | 2021 | 41 | 0.050 |
Why?
|
| Cell Separation | 1 | 2020 | 92 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 122 | 0.040 |
Why?
|
| Bone Substitutes | 1 | 2019 | 9 | 0.040 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 67 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2019 | 45 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sclerosis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2019 | 82 | 0.040 |
Why?
|
| Swine | 1 | 2019 | 215 | 0.040 |
Why?
|
| Observer Variation | 1 | 2019 | 105 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 154 | 0.040 |
Why?
|
| Neovascularization, Physiologic | 1 | 2019 | 110 | 0.040 |
Why?
|
| Curettage | 1 | 2018 | 9 | 0.040 |
Why?
|
| Bone Cements | 1 | 2018 | 11 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 246 | 0.040 |
Why?
|
| Cell Line | 1 | 2019 | 435 | 0.040 |
Why?
|
| Bone Transplantation | 1 | 2018 | 45 | 0.040 |
Why?
|
| Tibia | 1 | 2018 | 56 | 0.040 |
Why?
|
| Hepatitis C, Chronic | 1 | 2018 | 77 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2017 | 2 | 0.040 |
Why?
|
| Itraconazole | 1 | 2017 | 6 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 81 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2017 | 40 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 51 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 423 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2018 | 73 | 0.040 |
Why?
|
| Patient Selection | 1 | 2019 | 276 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 767 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 762 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 876 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 145 | 0.030 |
Why?
|
| Fractures, Closed | 1 | 2015 | 9 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 49 | 0.030 |
Why?
|
| Wrist Joint | 1 | 2015 | 60 | 0.030 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 291 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 187 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 322 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 517 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2019 | 656 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2015 | 240 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2015 | 178 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 232 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2265 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 2282 | 0.020 |
Why?
|